Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2684431000168112 | Olmesartan HCT 40/25 (GPPL) (hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
2684441000168115 | Olmesartan HCT 40/25 (GPPL) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Olmesartan HCT 40/25 (GPPL) (hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | Is a | Olmesartan HCT 40/25 (GPPL) | true | Inferred relationship | Some | ||
Olmesartan HCT 40/25 (GPPL) (hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | Is a | olmesartan medoxomil 40 mg + hydrochlorothiazide 25 mg tablet | true | Inferred relationship | Some | ||
Olmesartan HCT 40/25 (GPPL) (hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Olmesartan HCT 40/25 (GPPL) (hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
Olmesartan HCT 40/25 (GPPL) (hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | has unit of use | tablet | true | Inferred relationship | Some | 1732718378 | |
Olmesartan HCT 40/25 (GPPL) (hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | has intended active ingredient | olmesartan | true | Inferred relationship | Some | 1732718377 | |
Olmesartan HCT 40/25 (GPPL) (hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | has Australian BoSS | olmesartan medoxomil | true | Inferred relationship | Some | 1732718377 | |
Olmesartan HCT 40/25 (GPPL) (hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | has intended active ingredient | hydrochlorothiazide | true | Inferred relationship | Some | 1381381310 | |
Olmesartan HCT 40/25 (GPPL) (hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | has Australian BoSS | hydrochlorothiazide | true | Inferred relationship | Some | 1381381310 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Olmesartan HCT 40/25 (GPPL) tablet, 30, blister pack | has TPUU | True | Olmesartan HCT 40/25 (GPPL) (hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | Inferred relationship | Some | 1 |
Olmesartan HCT 40/25 (GPPL) tablet, 10 | has TPUU | True | Olmesartan HCT 40/25 (GPPL) (hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | Inferred relationship | Some | 1 |
Olmesartan HCT 40/25 (GPPL) (hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet, 30 tablets (trade product pack) | has TPUU | True | Olmesartan HCT 40/25 (GPPL) (hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | Inferred relationship | Some | 1 |
Olmesartan HCT 40/25 (GPPL) tablet, 10, blister pack | has TPUU | True | Olmesartan HCT 40/25 (GPPL) (hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set